![Darrell Sleep](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Darrell Sleep
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Cobra Biologics Ltd.
![]() Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Darrell Sleep
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Cobra Biologics Holding AB
![]() Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
Cobra Biologics Holdings Ltd.
![]() Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Biotechnology | Director of Finance/CFO Human Resources Officer | |
Aesica Formulation Development Ltd.
![]() Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Empros Pharma AB
![]() Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Corporate Officer/Principal | |
B&E Participation, Inc. | Chairman | ||
Recipharm Ltd.
![]() Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Sixera Pharma AB
![]() Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Recipharm Verwaltungs GmbH
![]() Recipharm Verwaltungs GmbH Financial ConglomeratesFinance Part of Recipharm AB, Recipharm Verwaltungs GmbH is an investment holding German company. The company is based in Wasserburg am Inn, Germany. The CEOs of the company are Michael Isele, Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
Amarna Therapeutics BV
![]() Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Chairman | |
Recipharm Holdings Ltd.
![]() Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. | Miscellaneous | Director/Board Member | |
SymCel AB
![]() SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member | |
Aesica Holdco Ltd.
![]() Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The company is based in Hemel Hempstead, UK. | Pharmaceuticals: Major | Director/Board Member | |
Flerie Participation AB
![]() Flerie Participation AB Financial ConglomeratesFinance Flerie Participation AB is an investment holding Swedish company. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Recipharm Fontaine SAS
![]() Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Fontaine SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Fontaine-les-Dijon, France. The company was founded in 2008. Pascal Prudent has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman | |
Recipharm Monts SAS
![]() Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Monts SAS is a company that manufactures sterile injectable anesthetic products. The company is based in Monts, France. Carl Ericson has been the CEO of the French company since 2019. | Pharmaceuticals: Major | Chairman | |
Zentricity Holding AB
![]() Zentricity Holding AB Financial ConglomeratesFinance Zentricity Holding AB provides investment services. It offers venture capital to startup companies. The company is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
NANOLOGICA AB | Pharmaceuticals: Major | Director/Board Member | |
Buzzard Pharmaceuticals AB
![]() Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member | |
Consort Medical GmbH
![]() Consort Medical GmbH Financial ConglomeratesFinance Part of Recipharm AB, Consort Medical GmbH is a German company that functions as an investment holding company. The company is based in Monheim, Germany. The CEO of the company is Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
Prokarium Holdings Ltd.
![]() Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman | |
Prokarium Ltd.
![]() Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
TOLERANZIA AB | Biotechnology | Director/Board Member | |
NorthX Biologics Matfors AB
![]() NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Biotechnology | Chairman | |
Bohus HoldCo AB
![]() Bohus HoldCo AB Chemicals: Major DiversifiedProcess Industries Bohus BioTech AB is a Swedish company that manufactures and develops hyaluronic acid products. The company is based in Stromstad, Sweden and has subsidiaries in Sweden. The company was founded in 1992 by Daniel C. Ogbonnaya. | Chemicals: Major Diversified | Director/Board Member | |
XINTELA AB | Biotechnology | Director/Board Member | |
Provell Pharmaceuticals LLC
![]() Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA. | Medical Distributors | Director/Board Member | |
Zentricity International AB
![]() Zentricity International AB Financial ConglomeratesFinance Zentricity International AB provides investment services. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Flerie Invest AB
![]() Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Chairman | |
RECIPHARM AB (PUBL) | Biotechnology | Founder | |
Royal Swedish Academy of Engineering Sciences
![]() Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
University of Uppsala | College/University | Masters Business Admin | |
OxThera AB
![]() OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Chief Operating Officer | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Octapharma AB
![]() Octapharma AB Pharmaceuticals: MajorHealth Technology Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Metcon Medicin AB
![]() Metcon Medicin AB Pharmaceuticals: MajorHealth Technology MetCon Medicin AB develops and manufactures pharmaceutical products. Its products are used for oral administration and stabilizing blood sugar levels. The company's products are used for the treatment of diabetes and other metabolic diseases. MetCon Medicin was founded by Dr. Ulf Smith and Dr. Mats Lake in 1999 and is headquartered in Lidingo, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Royal Institute of Technology | College/University | Graduate Degree | |
Biosource Europe AB | Director/Board Member | ||
Epicyt Pharma AB
![]() Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Pharmaceuticals: Major | Chairman | |
KAHR Medical Ltd.
![]() KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
SwedenBIO Service AB
![]() SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Recip AB
![]() Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Linköping Institute of Technology | College/University | Graduate Degree | |
Trimeta LLC | Chairman |
Statistik
International
Schweden | 34 |
Vereinigtes Königreich | 8 |
Vereinigte Staaten | 5 |
Deutschland | 3 |
Frankreich | 3 |
Sektoral
Health Technology | 29 |
Finance | 9 |
Commercial Services | 5 |
Consumer Services | 4 |
Health Services | 2 |
Operativ
Director/Board Member | 32 |
Chairman | 13 |
Chief Executive Officer | 8 |
Corporate Officer/Principal | 7 |
President | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Darrell Sleep
- Unternehmensverbindungen